EGBERTSON; Melissa

Patent Applications and Registrations

Patent applications and USPTO patent grants for EGBERTSON; Melissa.The latest application filed is for "pyranopyrazole and pyrazolopyridine immunomodulators for treatment of autoimmune diseases".

Company Profile

6.23.23

EGBERTSON; Melissa - Ambler PA
Egbertson; Melissa - West Point PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyranopyrazole And Pyrazolopyridine Immunomodulators For Treatment Of Autoimmune Diseases App 20220213114 - PONDA; Manish P. ; et al.	2022-07-07
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,339,156 - Acton, III , et al. May 24, 2	2022-05-24
Pyranopyrazole and pyrazolopyridine immunomodulators for treatment of autoimmune diseases Grant 11,312,723 - Ponda , et al. April 26, 2	2022-04-26
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20210395224 - Acton, III; John J. ; et al.	2021-12-23
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20210380580 - ACTON, III; John J. ; et al.	2021-12-09
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,149,036 - Acton, III , et al. October 19, 2	2021-10-19
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,933,056 - Acton, III , et al. March 2, 2	2021-03-02
Pyranopyrazole And Pyrazolopyridine Immunomodulators For Treatment Of Autoimmune Diseases App 20200369677 - PONDA; Manish P. ; et al.	2020-11-26
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200207758 - ACTON, III; John J. ; et al.	2020-07-02
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200069671 - Acton, III; John J. ; et al.	2020-03-05
Aminoacylindazole immunomodulators for treatment of autoimmune diseases Grant 10,538,512 - Ponda , et al. Ja	2020-01-21
Aminoacylindazole Immunomodulators For Treatment Of Autoimmune Diseases App 20190202811 - PONDA; Manish P. ; et al.	2019-07-04
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190000824 - Acton, III; John J. ; et al.	2019-01-03
Pyrimidone carboxamide compounds as PDE2 inhibitors Grant 9,815,796 - Shen , et al. November 14, 2	2017-11-14
Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels Grant 9,586,968 - Layton , et al. March 7, 2	2017-03-07
Pyrimidone Carboxamide Compounds As Pde2 Inhibitors App 20170015633 - Shen; Dong Ming ; et al.	2017-01-19
Bicycloamine-substituted-n-benzenesulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20170002008 - Layton; Mark E. ; et al.	2017-01-05
TrkA kinase inhibitors, compositions and methods thereof Grant 9,181,261 - Stachel , et al. November 10, 2	2015-11-10
TrkA Kinase Inhibitors, Compositions and Methods Thereof App 20150141428 - Stachel; Shawn J. ; et al.	2015-05-21
TRPA1 antagonists Grant 8,829,196 - Bilodeau , et al. September 9, 2	2014-09-09
Quinolinone PDE2 inhibitors Grant 8,680,116 - DeLeon , et al. March 25, 2	2014-03-25
Hiv Integrase Inhibitors App 20130178468 - Vacca; Joseph P. ; et al.	2013-07-11
Novel Trpa1 Antagonists App 20120196894 - Bilodeau; Mark T. ; et al.	2012-08-02
Quinolinone PDE2 Inhibitors App 20120115885 - De Leon; Pablo ; et al.	2012-05-10
HIV integrase inhibitors Grant 7,598,264 - Han , et al. October 6, 2	2009-10-06
Hiv Integrase Inhibitors App 20090054399 - Vacca; Joseph P. ; et al.	2009-02-26
Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors Grant 7,435,735 - Wai , et al. October 14, 2	2008-10-14
N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors Grant 7,323,460 - Egbertson , et al. January 29, 2	2008-01-29
Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors Grant 7,279,487 - Egbertson , et al. October 9, 2	2007-10-09
Hiv integrase inhibitors App 20070179196 - Han; Wei ; et al.	2007-08-02
Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors App 20070093496 - Wai; John S. ; et al.	2007-04-26
Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors App 20050176718 - Anthony, Neville J. ; et al.	2005-08-11
N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors App 20050176955 - Egbertson, Melissa ; et al.	2005-08-11
Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors Grant 6,921,759 - Anthony , et al. July 26, 2	2005-07-26
Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors App 20050119482 - Egbertson, Melissa ; et al.	2005-06-02
Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors App 20030055071 - Anthony, Neville J. ; et al.	2003-03-20
HIV integrase inhibitors Grant 6,306,891 - Selnick , et al. October 23, 2	2001-10-23
Fibrinogen receptor antagonists Grant 5,416,099 - Hartman , et al. * May 16, 1	1995-05-16
Fibrinogen receptor antagonists Grant 5,397,791 - Hartman , et al. March 14, 1	1995-03-14
Fibrinogen receptor antagonists Grant 5,272,158 - Hartman , et al. December 21, 1	1993-12-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.